Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001171843-25-004721
Filing Date
2025-07-25
Accepted
2025-07-25 16:46:19
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 s3_071625.htm S-3 459515
2 EXHIBIT 4.3 exh_43.htm EX-4.3 389143
3 EXHIBIT 4.4 exh_44.htm EX-4.4 407923
4 EXHIBIT 5.1 exh_51.htm EX-5.1 27864
5 EXHIBIT 5.2 exh_52.htm EX-5.2 18798
6 EXHIBIT 23.1 exh_231.htm EX-23.1 3612
7 CALCULATION OF FILING FEE TABLES exh_107.htm EX-FILING FEES 66832
8 GRAPHIC logo.jpg GRAPHIC 13997
9 GRAPHIC lowenstein.jpg GRAPHIC 4329
10 GRAPHIC lowensteinfoot.jpg GRAPHIC 6619
11 GRAPHIC exh51hdr.jpg GRAPHIC 7940
12 GRAPHIC mnplogo.jpg GRAPHIC 4311
13 GRAPHIC mnpsig.jpg GRAPHIC 2477
14 GRAPHIC mnpfoot.jpg GRAPHIC 9129
  Complete submission text file 0001171843-25-004721.txt   1442929
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-288966 | Film No.: 251152164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)